Abdul-Aziz N, Abdulhameed N, Marellapudi A, Shah H. Multiple Sclerosis anti-CD20 (Ocrelizumab) therapy inducing hypogammaglobulinemia. Translation. 2023;11(3). doi:10.46570/utjms.vol11-2023-836